James A Geraghty insider trades
Open-market stock purchases and sales by James A Geraghty, Director at Voyager Therapeutics, Inc, from SEC Form 4 filings since Dec 31, 2009.
Track record: 0% of 3 scored buys are up 5% or more since purchase, averaging -75%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 9, 2026 | VYGR Voyager Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- VYGR Voyager Therapeutics, Inc: 2 buys, last Jun 9, 2026
- FULC Fulcrum Therapeutics, Inc: 1 buy, last Jun 26, 2025
- PIRS Pieris Pharmaceuticals, Inc: 3 buys, last Dec 12, 2024
- ORTX Orchard Therapeutics plc: other filings, last Jan 24, 2024
- IDRA Idera Pharmaceuticals, Inc: 6 buys, last Jun 23, 2022
- JNP Juniper Pharmaceuticals Inc: 7 buys, last Aug 14, 2018
- GENZ Genzyme Corp: 2 sales, last Apr 4, 2011
- GTCB GTC Biotherapeutics Inc: other filings, last Dec 31, 2009